Don Schneider, Piper Sandler deputy head of U.S. policy, and Marc Goldwein, CRFB SVP and senior policy director, join CNBC's ...

Piper Sandler analyst Alexander Potter upgraded Aptiv (APTV) to Neutral from Underweight with a price target of $65, up from $53, after the ...

Elon Musk's Tesla could deliver a choppy H1 given tailwinds from Donald Trump's EV policies, uncertainties in deliveries, and gross margin.

Trupanion, Inc. (NASDAQ:TRUP), currently trading at $46.52, received an upgrade in its stock rating from Piper Sandler analysts, moving from Neutral to Overweight. Alongside the rating change, the ...

Piper Sandler analyst Andrew Liesch maintained a Hold rating on Great Southern Bancorp (GSBC – Research Report) today and set a price target of ...

Salesforce shows potential for growth with dominant market share and AI-driven interest from Agentforce, according to Piper ...

Tesla remains the “top buy-and-hold” stock for analysts at Piper Sandler, who massively raised their price target for the ...

Intra-Cellular Therapies Inc (ITCI) stock saw a modest uptick, ending the day at $126.5 which represents a slight increase of $0.30 or 0.24% from the prior close of $126.2. The stock opened at $126.64 ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...

Tesla (TSLA) slips as President Trump considers eliminating EV tax credits and subsidies, while Piper Sandler analysts raise ...

Tesla Inc.'s stock shed early gains Tuesday that came on expectations that Chief Executive Elon Musk's close relationship with the new administration will help the electric-vehicle maker, with ...

Investors are expecting Musk to benefit more broadly from Trump 2.0, possibly through friendlier rules on self-driving or for one of his other initiatives beyond Tesla. Tesla's stock (TSLA) has gained ...